The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.50
Bid: 2.44
Ask: 2.60
Change: 0.00 (0.00%)
Spread: 0.16 (6.557%)
Open: 2.50
High: 0.00
Low: 0.00
Prev. Close: 2.50
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Investment in Poland-Offer Unconditional

29 Nov 2017 07:00

RNS Number : 7878X
Globalworth Real Estate Inv Ltd
29 November 2017
 

29 November 2017

 

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

Further update on Investment in Poland - Tender Offer now unconditional in all respects

Globalworth announced on 4 October 2017 (the "Announcement") that its subsidiary Globalworth Asset Managers SRL ("GAM") had entered into a conditional investment agreement to acquire a minimum of 50.01% and up to 67.90% of the issued share capital of Griffin Premium RE.. N.V. ("GPRE"), a Dutch entity listed on the Warsaw Stock Exchange, (the "Acquisition") to be effected by way of a public tender offer (the "Tender Offer").

On 16 November 2017, the Company announced that resolutions had been passed at an EGM of GPRE satisfying a condition of the Tender Offer. The Tender Offer remained conditional upon satisfaction of the acceptance condition stated in the Tender Offer document and execution of an organisation agreement (the "Organisation Agreement") between the Company and GPRE.

The Board of Globalworth is pleased to announce that both these conditions have been satisfied and that all conditions precedent to the Tender Offer have now been satisfied or waived, and consequently the Tender Offer has become unconditional in all respects.

Upon closing of the Tender Offer, approximately 106.0 million shares, constituting 67.90% of the total number of the votes at the general meeting of GPRE, were tendered in the Tender Offer, thereby satisfying the acceptance condition stated in the Tender Offer document. The total consideration payable under the Tender Offer will be PLN 583m (€138m2) which will be met from the Company's existing cash resources.

In addition, on 28 November 2017, the Company entered into the Organisation Agreement with GPRE. Under the Organisation Agreement, GPRE has undertaken to carry out certain actions following and resulting from the acquisition of control by GAM. These actions include, among others, the implementation of certain procedures and changes in the operations of GPRE in order to comply with practices observed by Globalworth group companies. The parties to the Organisation Agreement have also agreed on principles of entering into related party transactions and intragroup disclosure of confidential information in compliance with applicable law and regulations.

The Company is now in the process of concluding the Tender Offer settlement and closing procedures and currently expects the remaining completion steps to be concluded by 6 December 2017.

By way of update to the Company's announcement on 27 November 2017, adjusted on a pro forma, consolidated basis for the Acquisition, upon full consolidation of GPRE, the Company estimates that, as a result of acquiring an interest of 67.90% of the issued share capital of GPRE at a discount to GPRE's EPRA NAV, the Company's unaudited EPRA NAV per share (the "Adjusted EPRA NAV") as at 30 September 2017 should increase to approximately €8.64. This is stated before the effects of any H2 2017 revaluation movements and is based on currently available information and a number of assumptions1. The Company's actual Adjusted EPRA NAV per share will vary depending upon, among other things, the actual balances as at the closing date of the acquisition of GPRE.

Dimitris Raptis, Deputy Chief Executive Officer and Chief Investment Officer of the Company, commented: "We are very pleased to have successfully concluded the Tender Offer and were delighted to accept tenders giving us an aggregate 67.90% shareholding in GPRE while maintaining the listing on the Warsaw Stock Exchange. Our expansion into Poland, the largest market in Central and Eastern Europe, is a pivotal development in Globalworth's strategy to establish itself as the region's leading office investor, present in the two key markets of Poland and Romania. In conjunction with the already announced acquisitions GPRE is now moving into its next phase of growth and value creation."

Terms which are not otherwise defined in this announcement have the meanings given to them in the Announcement.

Enquiries:

 

Andrew Cox Tel: +44 20 3026 4027

Head of Investor Relations & Corporate Development

 

Panmure Gordon (Nominated Adviser and Joint Broker) Tel: +44 20 7886 2500

Andrew Potts

 

Jefferies (Joint Broker) Tel: +44 20 7029 8000

Stuart Klein

 

Milbourne (Public Relations) Tel: +44 7921 881 800

Tim Draper

 

About Globalworth

 

Globalworth is a real estate investment company active in Central and Eastern Europe, and has become the leading office investor in the Romanian real estate market. Globalworth acquires, develops and directly manages high-quality office and logistics/light-industrial real estate assets in prime locations, through which it benefits from a strong rental income profile from high quality tenants from around the globe. With approximately 70 professionals managing it, Globalworth's portfolio, as at 30 September 2017, was valued in excess of €1 billion, of which 90% is in income-producing assets and over 80% in the office sector. Globalworth has a strong and supportive investor base, having been listed on the AIM Market of London Stock Exchange since 2013 and in 2017 issued its debut Eurobond on the Irish and Bucharest stock exchanges.

 

GPRE is a pure-play Polish real estate platform that primarily owns high-quality office and mixed-use assets located in Warsaw and across a number of other key cities, notably Wroclaw, Lodz, Krakow and Katowice. Its portfolio comprises six office and three mixed-use (office and retail) properties, and benefits from a further pipeline of contracted acquisitions. For more information please refer to related regulatory announcements.

 

NOTE

 

1. The Company's estimated Adjusted EPRA NAV per share of approximately €8.64 as at 30 September 2017 has been included for information purposes only and is subject to a number of assumptions, including: (a) that completion of the Company's acquisition of GPRE occurred as at 30 September 2017; (b) that 67.90% of the issued share capital of GPRE is acquired by the Company; (c) an estimated PLN to EUR exchange rate; and (d) an estimated amount for the transaction costs related to the Acquisition. As a result, even though management of the Company believes these assumptions to be reasonable, the estimated Adjusted EPRA NAV per share as at 30 September 2017 describes a hypothetical situation and has been prepared solely for illustrative purposes. It does not purport to represent what the Company's actual pro forma consolidated EPRA NAV per share may be upon completion of the acquisition of GPRE nor is it necessarily indicative of the Company's future consolidated EPRA NAV per share. The Company's actual pro forma consolidated EPRA NAV per share may differ significantly from the estimated Adjusted EPRA NAV for a number of reasons, including, but not limited to, the actual balances as at the closing date of the acquisition of GPRE and differences between amounts assumed and the actual amounts.

 

2. Assumed EURPLN Exchange Rate of 4.23, subject to final settlement

 

 

IMPORTANT NOTICE:

 

No public offer of securities is being made by virtue of this announcement.

 

This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

 

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURBLBMTMBBTMTR
Date   Source Headline
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.